Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Spectrum Pharmaceuticals Stock Quote

Spectrum Pharmaceuticals (NASDAQ: SPPI)

Some price data may be temporarily unavailable.

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Spectrum Pharmaceuticals Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
SPPI +26.69% -95.09% -45.27% -99%
S&P +29.03% +83.23% +12.86% +649%

Spectrum Pharmaceuticals Company Info

Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development and commercialization of a pipeline of novel and targeted oncology therapies. Its product pipeline includes: Eflapegrastim, Poziotinib, and IGN002. The company was founded in December 1987 and is headquartered in Boston, MA.

News & Analysis

The Fool has written over 100 articles on Spectrum Pharmaceuticals.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.